There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jazz Pharmaceuticals (NASDAQ:JAZZ), Spark Therapeutics (NASDAQ:ONCE) and DENTSPLY SIRONA Inc (NASDAQ:XRAY) with bullish sentiments.
Jazz Pharmaceuticals (JAZZ)
Piper Jaffray analyst David Amsellem reiterated a Buy rating on Jazz Pharmaceuticals yesterday and set a price target of $213. The company’s shares closed yesterday at $179.90, close to its 52-week high of $184.
According to TipRanks.com, Amsellem is a 1-star analyst with an average return of -1.2% and a 45.8% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as Bausch Health Companies Inc, Eagle Pharmaceuticals Inc, and Supernus Pharmaceuticals.
Jazz Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $200.91, which is an 11.7% upside from current levels. In a report released yesterday, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $203 price target.
.
See today’s analyst top recommended stocks >>
Spark Therapeutics (ONCE)
Stifel Nicolaus analyst Stephen Willey reiterated a Buy rating on Spark Therapeutics yesterday and set a price target of $68. The company’s shares closed yesterday at $56.01.
According to TipRanks.com, Willey is a 5-star analyst with an average return of 20.9% and a 50.9% success rate. Willey covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals Inc, Alexion Pharmaceuticals, and Lexicon Pharmaceuticals.
Spark Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $74.18, which is a 32.4% upside from current levels. In a report released yesterday, William Blair also maintained a Buy rating on the stock.
.
DENTSPLY SIRONA Inc (XRAY)
In a report released yesterday, Jonathan Block from Stifel Nicolaus reiterated a Buy rating on DENTSPLY SIRONA Inc, with a price target of $46. The company’s shares closed yesterday at $39.41, close to its 52-week low of $38.83.
According to TipRanks.com, Block is a 5-star analyst with an average return of 23.1% and a 75.9% success rate. Block covers the Healthcare sector, focusing on stocks such as Idexx Laboratories, Align Tech, and Aratana.
DENTSPLY SIRONA Inc has an analyst consensus of Moderate Buy, with a price target consensus of $46.33.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
